搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Daily
6 小时
GLP-1 Agonists: Game Changer in Treating Obesity and Boosting Fertility, Review Reveals
USA: A recent narrative review published in Fertility and Sterility highlights the importance of comprehensive care for ...
8 小时
Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
TCTMD
12 小时
GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes
The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.
19 小时
on MSN
Here’s What Ozempic Does To Your Brain, According To Doctors Who Prescribe It
By now, you probably know that Ozempic can have a big impact on your body. But what might be news to you is that it also ...
Rolling Out
19 小时
7 critical Ozempic benefits and risks for transformative diabetes management
Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...
The Brighterside of News on MSN
1 天
Revolutionary obesity and diabetes treatment burns energy and reduces appetite without side ...
Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...
The American Journal of Managed Care
1 天
For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...
Futurism
1 天
Mounjaro Appears to Be Extremely Effective at Preventing Diabetes
A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.
Renal & Urology News
2 天
SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
pulmonologyadvisor
2 天
GLP-1 Drug Shortages: How Do They Affect Patients With Diabetes?
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
gastroenterologyadvisor
2 天
GLP-1RA Drugs, SGLT2 Inhibitors Prevent Liver Disease in T2D
GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.
Endocrinology Advisor
2 天
GLP-1RA Prescribing Trends, Access Showcased at ObesityWeek® 2024
GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈